News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InNexus Biotechnology Inc. (IXS) Hires New Chief Financial Officer


5/11/2011 10:23:54 AM

InNexus Biotechnology Inc. (TSX:IXS.V), a leading drug development company commercializing the next generation of antibodies based on its proprietary DXL™ and Transmab™ technologies, today announced that it has appointed Christie Amato as its Chief Financial Officer. Mrs. Amato replaces David Petulla and assumed her new position on May 9th 2011. She will oversee InNexus non-research and development administrative functions in addition to her financial management responsibilities.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES